ASLAN Pharmaceuticals (ASLN) Competitors $0.60 0.00 (0.00%) As of 08/21/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsOptions ChainSEC FilingsTrendsBuy This Stock ASLN vs. TTNP, CPHI, VIVS, PALI, INM, GTBP, CDT, GLTO, REVB, and BDRXShould you be buying ASLAN Pharmaceuticals stock or one of its competitors? The main competitors of ASLAN Pharmaceuticals include Titan Pharmaceuticals (TTNP), China Pharma (CPHI), VivoSim Labs (VIVS), Palisade Bio (PALI), InMed Pharmaceuticals (INM), GT Biopharma (GTBP), Conduit Pharmaceuticals (CDT), Galecto (GLTO), Revelation Biosciences (REVB), and Biodexa Pharmaceuticals (BDRX). These companies are all part of the "pharmaceutical products" industry. ASLAN Pharmaceuticals vs. Its Competitors Titan Pharmaceuticals China Pharma VivoSim Labs Palisade Bio InMed Pharmaceuticals GT Biopharma Conduit Pharmaceuticals Galecto Revelation Biosciences Biodexa Pharmaceuticals Titan Pharmaceuticals (NASDAQ:TTNP) and ASLAN Pharmaceuticals (NASDAQ:ASLN) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, dividends, profitability, analyst recommendations, institutional ownership and risk. Is TTNP or ASLN more profitable? Titan Pharmaceuticals' return on equity of -108.60% beat ASLAN Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Titan PharmaceuticalsN/A -108.60% -95.64% ASLAN Pharmaceuticals N/A -8,454.87%-121.60% Do institutionals & insiders believe in TTNP or ASLN? 31.5% of Titan Pharmaceuticals shares are owned by institutional investors. Comparatively, 58.8% of ASLAN Pharmaceuticals shares are owned by institutional investors. 0.7% of Titan Pharmaceuticals shares are owned by company insiders. Comparatively, 4.7% of ASLAN Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the media refer more to TTNP or ASLN? In the previous week, Titan Pharmaceuticals had 1 more articles in the media than ASLAN Pharmaceuticals. MarketBeat recorded 1 mentions for Titan Pharmaceuticals and 0 mentions for ASLAN Pharmaceuticals. Titan Pharmaceuticals' average media sentiment score of 0.98 beat ASLAN Pharmaceuticals' score of 0.00 indicating that Titan Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Titan Pharmaceuticals Positive ASLAN Pharmaceuticals Neutral Which has more risk and volatility, TTNP or ASLN? Titan Pharmaceuticals has a beta of 1.29, meaning that its share price is 29% more volatile than the S&P 500. Comparatively, ASLAN Pharmaceuticals has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500. Which has preferable valuation & earnings, TTNP or ASLN? Titan Pharmaceuticals has higher earnings, but lower revenue than ASLAN Pharmaceuticals. Titan Pharmaceuticals is trading at a lower price-to-earnings ratio than ASLAN Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTitan Pharmaceuticals$180K35.68-$4.71M-$2.95-1.64ASLAN Pharmaceuticals$12M0.10-$44.22M-$21.92-0.03 SummaryTitan Pharmaceuticals beats ASLAN Pharmaceuticals on 7 of the 12 factors compared between the two stocks. Get ASLAN Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ASLN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ASLN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ASLN vs. The Competition Export to ExcelMetricASLAN PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.23M$832.54M$5.76B$9.58BDividend YieldN/A4.84%4.41%4.09%P/E Ratio-0.031.1731.1026.05Price / Sales0.1026.21459.33116.07Price / CashN/A19.5637.7358.48Price / Book-0.096.659.536.61Net Income-$44.22M-$4.94M$3.26B$265.56M7 Day PerformanceN/A0.95%2.11%1.98%1 Month PerformanceN/A2.99%5.12%1.33%1 Year PerformanceN/A11.85%31.25%21.15% ASLAN Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ASLNASLAN PharmaceuticalsN/A$0.60flatN/AN/A$1.23M$12M-0.0330TTNPTitan Pharmaceuticals0.4886 of 5 stars$5.25+1.4%N/A-40.0%$4.78M$180K-1.7810CPHIChina PharmaN/A$1.43-3.1%N/A-92.7%$4.65M$4.30M0.00250Gap UpVIVSVivoSim LabsN/A$1.77-2.2%N/AN/A$4.60M$142K-0.1720PALIPalisade Bio2.4775 of 5 stars$0.76-4.6%$12.00+1,470.7%-79.7%$4.59M$250K-0.1910Gap DownINMInMed Pharmaceuticals0.5939 of 5 stars$2.26-1.7%N/A-73.6%$4.52M$4.60M-0.1910Positive NewsGTBPGT Biopharma1.8569 of 5 stars$1.36-8.8%$11.00+711.8%-50.0%$4.44MN/A-0.338Positive NewsCDTConduit Pharmaceuticals0.0602 of 5 stars$1.51-3.8%N/A-99.3%$4.42MN/A0.003GLTOGalecto3.6558 of 5 stars$3.33-1.3%$10.00+200.8%-77.5%$4.39MN/A-0.2540News CoveragePositive NewsShort Interest ↓Gap DownREVBRevelation Biosciences0.1079 of 5 stars$2.58-4.8%N/A-97.5%$4.39MN/A-0.0410Short Interest ↑Gap UpBDRXBiodexa Pharmaceuticals0.3355 of 5 stars$7.06-2.6%N/AN/A$4.37M$470K0.0020Gap Down Related Companies and Tools Related Companies TTNP Alternatives CPHI Alternatives VIVS Alternatives PALI Alternatives INM Alternatives GTBP Alternatives CDT Alternatives GLTO Alternatives REVB Alternatives BDRX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ASLN) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredUS attacks China, September 30?The White House just ordered more than 400 government agencies to prepare for the next phase of America’s econ...Stansberry Research | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ASLAN Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share ASLAN Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access